Animal Group
(n=6)
Initial Body Weight (gm) Final Body Weight (gm) Change in Body weight Kidney weight (gm) (kidney/Body Weight Ratio)
X 1000
Mean ± SD Mean ± SD gm (±) % (±) Mean ± SD Mean ± SD
Control 186.3 ± 4.6 205.3  ± 5.8a (+)19±2.8 (+)10.2% 0.8 ±0.01 3.9 ± 0.0003
Cisplatin 191.0 ± 4.7 183.8  ±  4.3ab (-) 7.5±0.8 (-) 3.9% 0.72 ±0.014d 4.2 ± 0.0002e
Misoprostol 184.3 ± 4.8 193.83 ± 7.11abc (+) 9.5±3.1 (+) 5.2% 0.74 ± 0.014d 3.8 ± 0.0012
MP + CP 185.8 ± 4.9 186.50 ± 5.6b (+) 0.8±1.9 (+) 0.43% 0.76 ± 0.012d 4.0 ± 0.0002e
All data are expressed as Mean ± SD, n=6. a: where P <0.001 of initial vs. final BW of same group; b: P <0.001 vs. final BW of controls; c: P<0.001 vs. final BW of cisplatintreated group; d: Significantly different of kidney weight at P.< 0.005) vs. control; e: Significantly different in kidney weight/body weight ratio vs. normal control group at P. < 0.005. (+) increase. (-): decrease.
Table 1: Effect of cisplatin and / or misoprostol on body weight & kidney weight/body weight ratio in rats.